Literature DB >> 10625689

Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor.

J D Mott1, C L Thomas, M T Rosenbach, K Takahara, D S Greenspan, M J Banda.   

Abstract

Activity of matrix metalloproteinases (MMP) is regulated by a family of proteins called tissue inhibitors of metalloproteinases (TIMP). Four TIMPs have been cloned, and their molecular weights range from 29,000 to 20,000. By reverse zymography, we have observed a metalloproteinase inhibitor with an apparent molecular weight of 16, 500 from medium conditioned by human brain tumor cells. Antibodies directed against TIMPs failed to react with the 16,500 molecular weight inhibitor, indicating that it was not a truncated form of a known TIMP. The inhibitor was isolated from conditioned medium using affinity and ion exchange chromatography. N-terminal sequences of the inhibitor matched amino acid sequences within the C-terminal domain of a protein known as procollagen C-terminal proteinase enhancer (PCPE). Thus, the inhibitor was named CT-PCPE. Comparison of the N-terminal domain of TIMP with CT-PCPE revealed that both contained six cysteine residues. As in the case of TIMP, reduction and alkylation abolished the inhibitory activity of CT-PCPE. Purified CT-PCPE inhibited MMP-2 with an IC(50) value much greater than that of TIMP-2. This implies that MMPs may not be the physiologic targets for CT-PCPE inhibition. However, these results suggest that CT-PCPE may constitute a new class of metalloproteinase inhibitor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625689     DOI: 10.1074/jbc.275.2.1384

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  A human protein containing multiple types of protease-inhibitory modules.

Authors:  M Trexler; L Bányai; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 3.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

4.  Binding of procollagen C-proteinase enhancer-1 (PCPE-1) to heparin/heparan sulfate: properties and role in PCPE-1 interaction with cells.

Authors:  Tali Weiss; Sylvie Ricard-Blum; Laura Moschcovich; Eitan Wineman; Shlomit Mesilaty; Efrat Kessler
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

Review 5.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 6.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 7.  Diverse biological functions of extracellular collagen processing enzymes.

Authors:  Philip C Trackman
Journal:  J Cell Biochem       Date:  2005-12-01       Impact factor: 4.429

8.  Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth.

Authors:  Elisa Giannoni; Francesca Buricchi; Giovanni Raugei; Giampietro Ramponi; Paola Chiarugi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 9.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

10.  Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production.

Authors:  David T Chang; Jacqueline A Jones; Howard Meyerson; Erica Colton; Il Keun Kwon; Takehisa Matsuda; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2008-12-01       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.